Mathew Martoma is an American former hedge fund trader. As a portfolio manager at S.A.C. ... to sell shares of pharmaceutical companies Wyeth and Elan Corporation based on tips from two doctors, including Sid Gilman of the University of Michigan, about the Alzheimer's disease drug bapineuzumab during clinical trials ...
Aug 29, 2017 ... Martoma extensively consulted Dr. Sidney Gilman - the tipper in this case ... Elan and Wyeth, in his portfolio, and encouraged SAC's principal, ...
Nov 20, 2012 ... Martoma met Gilman through paid consultations that took place between ... Gilman served as a consultant to Elan and Wyeth from 2003 ..... v. Granting such other and further relief as this Court may deem just and proper.
Mar 15, 2013 ... The SEC's complaint against CR Intrinsic, Martoma, and Dr. Gilman ... than $960 million in Elan and Wyeth securities in a little more than a ...
Suzanne M. Rivera and Alfred Goodman Gilman ...... ∗Alfred G. Gilman serves on the Board of Directors of Eli Lilly ...... fiery issues in 2009 in the case Wyeth v.
SEC v. CR Intrinsic Investors, LLC. ... suit against CR Intrinsic Investors, LLC (“CR Intrinsic”) and Matthew Martoma and Dr. Sidney Gilman. ... involving the clinical trial results for an Alzheimer's drug being jointly developed by Elan and Wyeth.
Oct 13, 2014 ... But in recent years two pharmaceutical companies, Elan and Wyeth, had worked ... By the time Gilman made his presentation, however, S.A.C. Capital no longer owned ...... Martoma was there, wearing a neat V-neck sweater.
He has served as a consultant for Wyeth, ReNeuron, Adamas, and Kyowa and has grant support from ... Address correspondence and reprint requests to Dr. Sid Gilman, Department of Neurology, ... Colosimo C, Vanacore N, Bonifati V, et al.
Penicillin V, the phenoxymethyl analogue of penicillin G, is a semisynthetic penicillin for oraluse; discussed here is the potassium salt of penicillin V (often called ...